Hexavalent chromium (Cr) compounds are respiratory carcinogens in humans and animals. Treatment of Chinese hamster ovary cells with 150 and 300 pM sodium chromate (Na2CrO4) for 2 hr decreased colony-forming efficiency by 46 and 92%, respectively. These treatments induced dosedependent internucleosomal fragmentation of cellular DNA beyond 24 hr after chromate treatment. This fragmentation pattern is characteristic of apoptosis as a mechanism of cell death. These treatments also induced an immediate inhibition of macromolecular synthesis and delayed progression of cells through S-phase of the cell cycle. Cell growth (as evidenced by DNA synthesis) was inhibited for at least 4 days and transcription remained suppressed for at least 32 hr. Many of the cells that did progress to metaphase exhibited chromosome damage. Chromate caused the dose-dependent formation of DNA single-strand breaks and DNA-protein cross-links, but these were repaired 8 and 24 hr after removal of the treatment, respectively. In contrast, Cr-DNA adducts (up to 1/100 base-pairs) were extremely resistant to repair and were still detectable even 5 days after treatment. Compared with other regions of the genome, DNA-protein cross-links and Cr adducts were preferentially associated with the nuclear matrix DNA of treated cells, which was 4.5-fold enriched in actively transcribed genes. Chromium adducts, formed on DNA in vitro at a similar level to that detected in nuclear matrix DNA, arrested the progression of a DNA polymerase in a sequence-specific manner, possibly through the formation of DNA-DNA cross-links. Total RNA and mRNA synthesis and induction of expression of the inducible GRP78 gene were suppressed in a concentration-and time-dependent manner by chromate. The effects of chromate on GRP78 induction correlated most closely with the presence of DNA-protein cross-links but suppression of total RNA and mRNA synthesis correlated with the presence of DNA-Cr adducts in cells. These results suggest that the persistent Cr-DNA adducts may be responsible for the protracted cell cycle delay and transcriptional inhibition caused by chromate. Escape from apoptosis may be one of the steps involved in chromate-induced carcinogenesis. -Environ Health Perspect 102(Suppl 3): 159-167 (1994).
Introduction
Hexavalent (VI) chromium compounds are carcinogenic to humans, potent inducers of tumors in experimental animals (1, 2) , and can neoplastically transform cells in culture (3) (4) (5) . They are also genotoxic (4, 6, 7) and can induce a spectrum of DNA damage (8) (9) (10) (11) (12) (13) , gene mutations (4, 5, 7) , sister chromatid exchanges (4, 14) , and chromo-somal aberrations (4, 15) . The mechanisms by which hexavalent chromium-induced toxicity and carcinogenicity are mediated is, however, currently poorly understood.
Potentially, carcinogen toxicity may occur by one of two mechanisms: necrosis or apoptosis (16) . These two types of cell death differ morphologically and biochemically. Necrotic cells exhibit an early characteristic cell swelling with the loss of the ionic gradient across the cell membrane and subsequent DNA degradation by released lysosomal enzymes (17) . Necrotic cell death does not appear to be cell cycle related. In contrast, cells dying by apoptosis undergo shrinkage while the ionic gradient across the cell membrane is maintained until later stages of the apoptotic process (18) . A characteristic feature of apoptosis is that DNA is fragmented internucleosomally before the loss of cell membrane integrity occurs. This is believed to result from the activation of a nuclear, Ca2+/Mg2+-dependent or pH-sensitive endonuclease, possibly DNase 11 (16, 19) . In many cases the process of apoptosis appears related to arrest of cells in a distinct phase of the cell cycle (18, 20, 21) . Carcinogen-treated cells that do overcome the cell cycle block may begin the process of tumor formation, suggesting that apoptosis could serve as a method of escape from the process of multistage carcinogenesis initiated by genotoxic agents.
Recently, several carcinogenic and chemotherapeutic agents, including methylprednisolone, 4-hydroxytamoxifen, methotrexate, 5-fluorouracil, 5-fluorodeoxyuridine, etoposide, N-methyl-N'-nitro-N-nitrosoguanidine, cisplatin, y-irradiation, and nitrogen mustard, have been shown to induce apoptosis (18, (20) (21) (22) (23) (24) . Recent studies in this laboratory have sought to understand the role of apoptosis in hexavalent chromium-induced toxicity and carcinogenicity. Treatment of Chinese hamster ovary (CHO) cells with toxic doses of sodium chromate was found to result in an immediate inhibition of cell growth, and in macromolecular synthesis; however, cell death was delayed for at least 24 hr. Between 24 and 72 hr post-treatment, considerable cell death occurred following an accumulation of cells in the S-phase of the cell cyde. Many ofthe cells that did progress to metaphase exhibited chromosome damage. Intemudeosomal fagmentation of cellular DNA was detected beyond 24 hr after chromate treatment. This fragmentation pattern is characteristic of apoptosis as a mechanism of cell death. Although treatment with 150 pM chromate induced several types of DNA damage, only chromium adducts remained unrepaired throughout the period when cell death occurred. This lesion was found to be preferentially associated with the nudear matrix, the putative site of replication and transcription in the cell (25) . Chromium-DNA adducts formed on a synthetic DNA (27) . RNA snthesis was essed by incorporation of [ H]uridine into total cytoplasmic RNA or mRNA as described previously (13) . GRP78 transcript levels were determined by Northern blot hybridization analysis as described by Manning et al. (13 Figure 5 ). These concentrations also suppressed mRNA synthesis to approximately 30 and 20% of control levels, respectively ( Figure 5 ). Suppression of transcription of both total and mRNA synthesis occurred immediately after treatment (13) and this suppression persisted for at least 32 hr ( Figure 5 ).
Chromate was found to inhibit the induction of expression of the inducible GRP78 gene (33) Figure 6A ). Cells treated with the 300 pM dose contained a much reduced level of cross-links at 24 hr compared with 0 hr, indicating that DNA repair had occurred. Figure 6B shows that chromium-DNA adducts were formed immediately after treatment of cells with [51Cr]-labeled Na2CrO4. After a slight reduction in adduct levels between 0 and 8 hr posttreatment, little further decrease occurred up to at least 32 hr ( Figure 6B ). adducts were still enriched in nuclear matrix DNA but at a slightly decreased level compared with 0 hr. Consistent with the data presented in Figure 6B ; however, there was little decrease in adduct levels in total nuclear DNA (Table 1) . Chromiuminduced DNA-protein cross-links, which were stable to 8 M urea and 2% SDS, were also enriched in the nuclear matrix (Table 1) . Consistent with the alkaline elution data presented in Figure 6A , the matrix-associated cross-links reached a°@ (Figure 7 , control lane). In contrast, treatment of pSV2neoTS with CrCl3 resulted in the concentration-dependent synthesis of truncated DNA molecules and a reduction in the amount of full-length product (Figure 7, 35 to 840 FM lanes) . Comparison of the size of these truncated molecules with the corresponding sequencing reactions ( Figure 7 ; G, A, T, and C lanes) indicated that the polymerase arrests occurred in a sequence-specific manner, in the GCrich (100% GC) and palindromic (65% GC) sequences and to a lesser extent in the AT-rich region (27% GC). This effect was most pronounced after treatment with the lower concentrations of CrCl3 ( (Table 3 ).
Discussion
The mechanisms of toxicity and carcinogenicity of hexavalent chromium compounds are currently poorly understood. Recently, however, several carcinogenic agents have been reported to induce apoptotic cell death in mammalian cells (18, (20) (21) (22) (23) (24) . Studies in this laboratory have therefore investigated whether apoptosis could be a mechanism by which chromium (VI) toxicity is mediated.
Treatment of CHO cells with cytotoxic concentrations of Na2CrO4 for 2 hr immediately inhibited cell growth (Figure 1 ) and DNA synthesis (Figure 4) , however no immediate cell death, as judged by trypan blue exclusion, occurred. Rapid inhibition of DNA replication by chromate has previously been reported by Levis et al. (37) . Bakke et al. (38) have previously reported that cells treated with chronic, high concentrations of chromate arrest in S-phase. CdCI2 and NiCI2 (39) . In addition, nitrogen mustard blocks progression of cells through this phase of the cell cycle prior to the onset of apoptosis (21) . Many of the cells that did progress to metaphase exhibited a high level of chromosome damage 24 hr after treatment with 150 pM chromate ( Table 2 ). The majority of the damage observed were chromatid lesions. These results are consistent with our previous finding that the relatively insoluble hexavalent chromium salt, lead (Figure 4) . In agreement with this possibility, although cells treated with 150 ,uM chromate grew slightly in the 24 hr following treatment, no growth was detected after treatment with the 300 FM concentration (Figure 1) (13) . A characteristic feature of apoptosis is that genomic DNA is fragmented intemucleosomally before the loss of cell membrane integrity occurs (18) . The size of DNA isolated from chromate-treated CHO cells was therefore analyzed on agarose gels. Dose-dependent internucleosomal DNA fragmentation was detected 48 hr after treatment of cells with Na2CrO4 ( Figure 2 ). Beyond 24 hr, a large number of cells became detached from the culture dishes ( Figure 1) . However, the membranes of these cells excluded trypan blue until between 48 and 72 hr after treatment. This is consistent with the known parameters of apoptotic cell death (16) . By 72 hr after treatment with either 15 or 300 pM chromate, considerable internudeosomal DNA fragmentation was apparent (Figure 3 ), suggesting that a large number of cells were undergoing apoptosis at this time.
Following a protracted inhibition of growth, chromate-treated cells began to recover, as evidenced by increased DNA synthesis on day 5 after treatment ( Figure 4 ). This was followed by an increase in cell number between days 6 and 8 ( Figure 1) . By day 7 after treatment, no DNA fragmentation was detected (Figure 3 ) suggesting that cells were no longer undergoing apoptosis at this time.
Treatment of CHO cells with 150 and 300 pM Na2CrO4 produced an immediate inhibition of protein synthesis (40) . Although the role of protein synthesis in apoptosis is unclear, the protein synthesis inhibitor cycloheximide has been reported to induce apoptosis in some instances (41) . It is therefore possible that the inhibition ofprotein synthesis produced by chromate could be involved in the initiation of apoptosis.
The formation and repair of DNA damage oi chromate-treated CHO cells was examined. DNA single-strand breaks, DNA-protein cross-links, and chromium DNA adducts were formed in a concentration-dependent manner; subsequently each type of damage was repaired at a different rate. Single-strand breaks were rapidly repaired, essentially within 8 hr (13) . The DNA-protein cross-links were more persistent than the strand breaks but were also repaired. By 24 hr no cross-links remained in cells treated with 150 pM chromate, while cells exposed to the 300 pM dose contained considerably lower levels of this type of damage at this time ( Figure 6A) .
The most persistent form of damage was chromium-DNA adducts that remained unrepaired for at least 32 hr ( Figure 6B ). This was the only type of damage to persist after the onset of cell death induced by both 150 and 300 pM chromate. In fact, adducts were still detectable in cells 5 days after treatment with the 150 pM dose (13) . Potentially therefore, chromium-DNA adducts could be involved in the mechanism of chromate-induced toxicity or carcinogenicity. Alternatively, DNA single-strand breaks or DNA-protein cross-links, although repaired prior to the onset of cell death, may cause the induction of a signal that induces cells to undergo apoptosis. A further possibility is that free radicals, produced as a result of the intracellular reduction of hexavalent chromium (8, (42) (43) (44) , may trigger apoptosis in affected cells.
Compared with total nuclear DNA, chromium-DNA adducts were found to be enriched in the nuclear matrix of CHO cells both immediately after treatment with 150 pM Na2CrO4 and 24 hr later (Table 1) . Both these data and those presented in Figure 6B suggest that chromium-DNA adducts are very poorly repaired in CHO cells.
The nudear matrix is believed to be the site of replication in the cell (25) . Potentially, chromium-DNA adducts associated with this fraction could interfere with replication and hence cause the inhibition of DNA synthesis and cellular growth observed after treatment of cells with Na2CrO4 (Figures 1, 4) . One mechanism by which this may occur would be if chromium-DNA adducts inhibited the action of DNA polymerases. To test this possibility, the effect of chromium-DNA adducts on the in vitro replication of DNA by Sequenase Version 2.0 T7 DNA polymerase was examined. For these experiments a synthetic template containing GC-and AT-rich regions and a palindrome sequence (pSV2neoTS) was employed. A reduced trivalent form of chromium is believed to be the species which binds to cellular DNA (45) . Treatment of pSV2neoTS with CrCl3 resulted in the dose-dependent formation of truncated molecules (Figure 7 ). After treatment with relatively low concentrations of CrCl3 (35, (36) . A similar inhibition of polymerase action via the formation of chromium (III)-induced DNA-DNA cross-links has previously been reported by Snow and Xu (45) . DNA-DNA cross-links formed in the nuclear matrix may therefore be a potential mechanism by which the chromate-induced inhibition of DNA synthesis is mediated.
As an alternative to the alkaline elution technique (29, 30) we have developed a procedure to isolate and quantify DNAprotein cross-links that are stable to sequential extraction with urea and SDS (Xu J, Manning FCR, Patierno SR, unpublished). Using this procedure, chromiuminduced DNA-protein cross-links were detected predominantly in the nuclear matrix fraction immediately after treatment of cells with 150 pM Na2CrO4 (Table 1) . Preferential cross-linking of nudear matrix proteins to DNA has also been reported by other workers (47, 48) . Consistent with the alkaline elution data presented in Figure  6A , the cross-links in the nuclear matrix reached a maximum level immediately after treatment with 150 pM Na2CrO4 but were essentially repaired 24 hr later ( Table 1) .
Treatment of CHO cells with 150 or 300 pM Na2CrO4 suppressed both total RNA and mRNA synthesis for at least 32 hr ( Figure 5 ). In cells treated with the lower chromate concentration, DNAchromium adducts were the only damage which persisted over this entire period ( Figure 6B ). In vitro, binding of chromium (III) has been found to interfere with the function of DNA templates, causing an increased number of initiation sites and the formation of truncated transcription products (49) . The chromium adducts formed in CHO cells may therefore exert an inhibitory effect on transcription, possibly by interfering with the action of RNA polymerases.
Immediately after treatment with 150 pM chromate, induction of expression of the inducible gene GRP78 by tunicamycin was almost completely inhibited ( Figure 5 ). In contrast, by 24 hr after treatment a recovery in GRP78 induction occurred ( Figure 5 ). This recovery correlated with the repair of DNA-protein cross-links at this time ( Figure 6A ; Table 1 ) but not with a general recovery of RNA synthesis ( Figure 5 ). Repair of single-strand breaks did not result in a recovery of GRP78 induction (13) . These results are similar to those of Hamilton and Wetterhahn (47) who reported that dichromate inhibited induction of the inducible genes 5-aminolevinate synthase and cytochrome PB1 P450 in chick embryo liver in vivo and that this inhibition correlated with the presence of DNA-protein cross-links.
It has been suggested that transcription of inducible genes may be particularly sensitive to DNA-protein cross-link formation because these genes typically have complex regulatory regions and often require numerous DNA-protein interactions for proper gene expression (50) . Potentially therefore, DNA-protein cross-links formed within the GRP78 promoter may inhibit the action of transacting factors required for gene induction. In fact, a number of transcription-factor binding sites, which are required for inducible gene expression, have been identified within the promoter region of the GRP78 gene (51) (52) (53) (54) . DNAprotein cross-links occurred predominantly in the nuclear matrix fraction after treatment with 150 pM chromate (Table 1); and repair of these cross-links 24 hr after treatment correlated with recovery of GRP78 induction ( Figure 5 ; Table 1 , respectively). It is therefore interesting that the nuclear matrix fraction was found to be enriched in GRP78 gene sequences compared with total nuclear DNA (Xu J, Manning FCR, Patierno SR, unpublished observations).
Only a partial recovery of GRP78 induction (56%) occurred when DNAprotein cross-links were repaired 24 hr after treatment with 150 pM chromate ( Figure 5 ). This suggests that chromium-DNA adducts, which were the only DNA damage still detectable at this time ( Figure  6B ; Table 1 ), may contribute to the observed inhibition of GRP78 induction. Alternatively, this effect may be due to the large number of cells undergoing apoptosis beyond 24 hr (Figure 1 ). In cells treated with 300 pM chromate, no recovery of GRP78 induction occurred even 24 hr after treatment (Figure 5 ), probably because of the extreme toxicity of this dose.
The results presented in this study indicate that the toxicity of hexavalent chromium compounds can occur via apoptosis. Cells which do not undergo apoptosis may contain chromate-induced chromosome damage in genes associated with tumor formation such as oncogenes or tumor suppressor genes. Escape from chromate-induced apoptosis could therefore represent an early step in chromateinduced carcinogenesis.
